Bliss GVS Pharma Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA129150
EBIT11159
Earning Per Share61
Expenses471629
Net Profit7423
Net Profit Margin133
Operating Profit Margin2220
Profit Before Tax10454
Dividends Per Share11
Operation Revenue597779

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
202298.23103.1086.202,445.2397.80
20221,739.202,486.90993.609,042.131,441.20
2022-1,229.80428.90-1,509.7011,900.64-1,372.50
20223,086.904,252.102,112.2018,985.902,991.10
20224,608.6011,319.203,405.8047,771.294,481.30
The EBITDA of Bliss GVS Pharma is 150 as of 3/25/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020212022
Operating Activities18404764135
Investing Activities50-74-48-47-93
Financing Activities-7617-6-21-24
Others00000
Net Cash Flow-8-17-7-419

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2022-17.7518.85-5.82-4.72
20221,108.65-333.28-520.49254.88
2022367.311,292.23-1,572.3287.22
20163,262.60-2,039.40-1,700.10-476.90
20183,907.15-3,370.81-1,539.26-1,002.92
The cash flow from Operating Activities of Bliss GVS Pharma is 135 as of 3/25/2023